You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 141 No. 5, April 1981 TABLE OF CONTENTS
  Archives
  •  Online Features
  BRIEF REPORT
 This Article
 •References
 •Full text PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citing articles on HighWire
 •Citing articles on Web of Science (4)
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

The Determination of Resectability of Lung Cancer by Fiberoptic Bronchoscopy

Howard M. Robbins, MD; Michael E. Sweet, MD; Steven E. Jefferson, MD; David A. Solomon, MD; Allan L. Goldman, MD

Arch Intern Med. 1981;141(5):649-650.


Abstract

• The usefulness of flexible fiberoptic bronchoscopy (FFB) in determining resectability of lung cancer in 152 patients was evaluated. Based on clinical and routine chest roentgenographic examinations, 66 patients (43%) had what were considered to be operable lesions greater than 3 cm in diameter or tumors associated with atelectasis or obstructive pneumonitis (but less than an entire lung), without evidence of pleural effusion or chest wall, mediastinal, or extrathoracic involvement. Forty-eight (73%) of the 66 patients were eventually found to have unresectable conditions. With FFB alone, the conditions of 32 (67%) of these 48 patients were staged as unresectable, so that more invasive procedures, eg, mediastinoscopy or thoracotomy, were required in only 12 and four patients, respectively. Early FFB should be done in potentially resectable cases in which these roentgenographic criteria are met. This procedure is easy, safe, and economical and would allow many patients with lung cancer to have the stage of their disease determined and be treated entirely as outpatients.

(Arch Intern Med 1981;141:649-650)



Author Affiliations

From the Department of Internal Medicine, Division of Pulmonary Disease, University of South Florida, College of Medicine, and James A. Haley Veterans Hospital, Tampa. Drs Robbins and Sweet are now with the Department of Respiratory Services, Martin Memorial Hospital, Stuart, Fla. Dr Jefferson is now with Borgess Hospital, Kalamazoo, Mich.


Footnotes

Accepted for publication April 7, 1980.

Reprint requests to 111C, 13000 N 30th St, Tampa, FL 33612 (Dr Goldman).



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Mediastinal Staging in Non-small-cell Lung Cancer
Malenka et al.
Med Decis Making 1989;9:231-242.
ABSTRACT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1981 American Medical Association. All Rights Reserved.